Elevance Health Q3 2026: revenue $51.43 billion, EPS $6.27 beats prior year

what happened

Health insurer Elevance Health published its third-quarter 2026 results. Revenue came in at $51.429 billion, up from $50.711 billion a year earlier, a 1.4% increase. Net income rose to $1.365 billion from $1.189 billion, or 14.8%. Diluted earnings per share were $6.27 against $5.32, a gain of 17.9%. Operating revenue grew only 0.7% over the quarter and 1.0% year to date. Higher premium rates and growth in CarelonRx products supported the figures. Total medical membership, however, fell 1.1%, driven by lower enrollment in Medicaid and Medicare Advantage. The company also launched a 2026–2027 transformation program covering organizational streamlining, technology upgrades and targeted workforce changes. These figures are taken from a TradingView summary based on a filing with the SEC.

why it matters

Profit growth on nearly flat revenue suggests that pricing and cost control, rather than business volume, drove the result. For markets, this is a signal for the broader US managed care sector, where investors are watching medical cost trends in Medicaid and Medicare Advantage closely.

market impact

ELV and US managed care stocks: profit growth despite smaller membership points to margins held up by pricing and cost control.

tags

instruments